Details for New Drug Application (NDA): 213394
✉ Email this page to a colleague
The generic ingredient in METFORMIN HYDROCHLORIDE is metformin hydrochloride; saxagliptin hydrochloride. There are forty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; saxagliptin hydrochloride profile page.
Summary for 213394
Tradename: | METFORMIN HYDROCHLORIDE |
Applicant: | Utopic Pharms |
Ingredient: | metformin hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 213394
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Aug 3, 2021 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM | ||||
Approval Date: | Aug 3, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription